A phase II study of mitomycin-C and S-1 as third-line chemotherapy in patients with advanced colorectal cancer

Author：                          

Publisher： Spandidos Publications

ISSN： 1792-1074

Source： Oncology Letters, Vol.2, Iss.6, 2011-01, pp. : 1253-1256

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase I study of bevacizumab combined with irinotecan and S-1 as second-line chemotherapy in patients with advanced colorectal cancer

By Kusaba Hitoshi   Esaki Taito   Kishimoto Junji   Uchino Keita   Arita Shuji   Kumagai Hozumi   Mitsugi Kenji   Akashi Koichi   Baba Eishi  

Cancer Chemotherapy and Pharmacology, Vol. 71, Iss. 1, 2013-01 ,pp. : 29-34

Springer Publishing Company

Access to resources Recommend Favorite

Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study

By Santini Daniele   Vincenzi Bruno   Schiavon Gaia   Di Seri Marisa   Virzí Vladimir   Spalletta Bruno   Caricato Marco   Coppola Roberto   Tonini Giuseppe  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 5, 2007-04 ,pp. : 613-620

Springer Publishing Company

Access to resources Recommend Favorite

Third-Line Hormonal Treatment with Exemestane in Postmenopausal Patients with Advanced Breast Cancer Progressing on Aminoglutethimide: a Phase II Multicentre Multinational Study

By Exemestane Study Group   Thurlimann B.   Paridaens R.   Serin D.   Bonneterre J.   Roche H.   Murray R.   di Salle E.   Lanzalone S.   Zurlo M.G.   Piscitelli G.  

European Journal of Cancer, Vol. 33, Iss. 11, 1997-10 ,pp. : 1767-1773

Elsevier

Access to resources Recommend Favorite

Prognostic factor analysis of third-line chemotherapy in patients with advanced gastric cancer

By Shim Hyun  

Gastric Cancer, Vol. 14, Iss. 3, 2011-08 ,pp. : 249-256

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of combined chemotherapy with irinotecan and S-1 (IRIS) plus bevacizumab in patients with inoperable recurrent or advanced colorectal cancer

By Komatsu Yoshito   Yuki Satoshi   Sogabe Susumu   Fukushima Hiraku   Nakatsumi Hiroshi   Kobayashi Yoshimitsu   Iwanaga Ichiro   Nakamura Michio   Hatanaka Kazuteru   Miyagishima Takuto   Kudo Mineo   Munakata Masaki   Meguro Takashi   Tateyama Miki   Sakata Yuh  

Acta Oncologica, Vol. 51, Iss. 7, 2012-09 ,pp. : 867-872

Informa Healthcare

Access to resources Recommend Favorite